Clinical Trial Update: Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients [Phase 4]

View source ↗

Summary

Clinical trial update on a Phase 4 study evaluating early tapering of immunosuppressive agents to modulate the immune system and potentially improve survival in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Bone Marrow Transplantation-related Disorder

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Acute Myeloid Leukemia, Disorder Related to Bone Marrow Transplantation | Phase 4 | Status: UNKNOWN